{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:17:05Z","timestamp":1787318225270,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2022YFC2702503"],"award-info":[{"award-number":["2022YFC2702503"]}]},{"name":"the International Science and Technology Cooperation Project of Hubei Province, China","award":["2021EHB025"],"award-info":[{"award-number":["2021EHB025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02393-x","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T21:28:56Z","timestamp":1745270936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of letrozole cotreatment in progestin-primed ovarian stimulation on IVF\/ICSI outcomes in POSEIDON group 3 and 4 poor responders: a retrospective cohort study"],"prefix":"10.1186","volume":"30","author":[{"given":"Luyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2393_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/352098","volume":"2014","author":"F Ubaldi","year":"2014","unstructured":"Ubaldi F, Vaiarelli A, D\u2019Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014: 352098. https:\/\/doi.org\/10.1155\/2014\/352098.","journal-title":"Biomed Res Int"},{"issue":"6","key":"2393_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3390\/ijms21062110","volume":"21","author":"A Abu-Musa","year":"2020","unstructured":"Abu-Musa A, Haahr T, Humaidan P. Novel physiology and definition of poor ovarian response; clinical recommendations. Int J Mol Sci. 2020;21(6):2110. https:\/\/doi.org\/10.3390\/ijms21062110.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2393_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.02.005.","journal-title":"Fertil Steril"},{"key":"2393_CR4","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","volume":"5","author":"P Humaidan","year":"2016","unstructured":"Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of \u2018Low prognosis patients in Assisted Reproductive Technology\u2019 and its proposed marker of successful outcome. FRes. 2016;5:2911. https:\/\/doi.org\/10.12688\/f1000research.10382.1.","journal-title":"FRes"},{"key":"2393_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"SC Esteves","year":"2018","unstructured":"Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why. Front Endocrinol (Lausanne). 2018;9:461. https:\/\/doi.org\/10.3389\/fendo.2018.00461.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2393_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.04.006","author":"N Qin","year":"2016","unstructured":"Qin N, Chen Q, Hong Q, et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril. 2016. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.04.006.","journal-title":"Fertil Steril"},{"issue":"6","key":"2393_CR7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.rbmo.2020.01.027","volume":"40","author":"P Alexandru","year":"2020","unstructured":"Alexandru P, Cekic SG, Yildiz S, Turkgeldi E, Ata B. Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis. Reprod Biomed Online. 2020;40(6):894\u2013903. https:\/\/doi.org\/10.1016\/j.rbmo.2020.01.027.","journal-title":"Reprod Biomed Online"},{"key":"2393_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705334","author":"Y Shi","year":"2018","unstructured":"Shi Y, Sun Y, Hao C, et al. Transfer of fresh versus frozen embryos in ovulatory women. New Engl J Med. 2018. https:\/\/doi.org\/10.1056\/NEJMoa1705334.","journal-title":"New Engl J Med."},{"key":"2393_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1231585","author":"JN Hugues","year":"2024","unstructured":"Hugues JN. Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy? Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1231585.","journal-title":"Front Endocrinol"},{"issue":"12","key":"2393_CR10","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101(12):2622\u20139. https:\/\/doi.org\/10.1172\/JCI2081.","journal-title":"J Clin Invest"},{"issue":"1","key":"2393_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/molehr\/gaq073","volume":"17","author":"ME Nielsen","year":"2011","unstructured":"Nielsen ME, Rasmussen IA, Kristensen SG, et al. In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Mol Hum Reprod. 2011;17(1):63\u201370. https:\/\/doi.org\/10.1093\/molehr\/gaq073.","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"2393_CR12","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1210\/me.2010-0006","volume":"24","author":"A Sen","year":"2010","unstructured":"Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010;24(7):1393\u2013403. https:\/\/doi.org\/10.1210\/me.2010-0006.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"2393_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5935\/1518-0557.20200086","volume":"25","author":"R Solernou","year":"2021","unstructured":"Solernou R, Peralta S, Casals G, et al. The Follicular Output Rate (FORT) as a method to evaluate transdermal testosterone efficacy in poor responders. JBRA Assist Reprod. 2021;25(2):229\u201334. https:\/\/doi.org\/10.5935\/1518-0557.20200086.","journal-title":"JBRA Assist Reprod"},{"issue":"6","key":"2393_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S. Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22(6):709\u201324. https:\/\/doi.org\/10.1093\/humupd\/dmw027.","journal-title":"Hum Reprod Update"},{"key":"2393_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13048-023-01259-2","volume":"16","author":"S Ayhan","year":"2023","unstructured":"Ayhan S, Hancerliogullari N, Guney G, et al. Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage? J Ovarian Res. 2023;16:184. https:\/\/doi.org\/10.1186\/s13048-023-01259-2.","journal-title":"J Ovarian Res"},{"issue":"8","key":"2393_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102139","volume":"50","author":"Y Qin","year":"2021","unstructured":"Qin Y. Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: a meta-analysis. J Gynecol Obstet Human Reprod. 2021;50(8): 102139. https:\/\/doi.org\/10.1016\/j.jogoh.2021.102139.","journal-title":"J Gynecol Obstet Human Reprod"},{"issue":"3","key":"2393_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/medicina60030407","volume":"60","author":"B Varl\u0131","year":"2024","unstructured":"Varl\u0131 B, \u015e\u00fck\u00fcr YE, \u00d6zdemir E\u00dc, et al. Evaluation of the impact of letrozole in combination with the GnRH antagonist ovarian stimulation protocol in patients expected to have a poor ovarian response (POSEIDON Groups 3 and 4). Medicina (Kaunas). 2024;60(3):407. https:\/\/doi.org\/10.3390\/medicina60030407.","journal-title":"Medicina (Kaunas)"},{"issue":"9","key":"2393_CR18","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s10815-020-01892-6","volume":"37","author":"BI Rose","year":"2020","unstructured":"Rose BI, Brown SE. A review of the physiology behind letrozole applications in infertility: are current protocols optimal? J Assist Reprod Genet. 2020;37(9):2093\u2013104. https:\/\/doi.org\/10.1007\/s10815-020-01892-6.","journal-title":"J Assist Reprod Genet"},{"key":"2393_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1072170","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lin J, Shen X, Zhu Q, Kuang Y. Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1072170.","journal-title":"Front Endocrinol"},{"issue":"5","key":"2393_CR20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/jog.15911","volume":"50","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang Y, Diao H, Jiang S, Zhang C. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization. J Obst Gynaecol Res. 2024;50(5):890\u20138. https:\/\/doi.org\/10.1111\/jog.15911.","journal-title":"J Obst Gynaecol Res"},{"issue":"10276","key":"2393_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. The Lancet. 2021;397(10276):839\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(21)00389-5.","journal-title":"The Lancet"},{"issue":"4 Suppl1","key":"2393_CR22","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.fertnstert.2019.08.077","volume":"112","author":"DK Gardner","year":"2019","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Reprint of: blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2019;112(4 Suppl1):e81\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.08.077.","journal-title":"Fertil Steril"},{"issue":"9","key":"2393_CR23","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/humrep\/deh359","volume":"19","author":"SK Goswami","year":"2004","unstructured":"Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod. 2004;19(9):2031\u20135. https:\/\/doi.org\/10.1093\/humrep\/deh359.","journal-title":"Hum Reprod"},{"issue":"4","key":"2393_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","volume":"19","author":"B Ozmen","year":"2009","unstructured":"Ozmen B, S\u00f6nmezer M, Atabekoglu CS, Olmus H. Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols. Reprod Biomed Online. 2009;19(4):478\u201385. https:\/\/doi.org\/10.1016\/j.rbmo.2009.05.007.","journal-title":"Reprod Biomed Online"},{"key":"2393_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/581451","volume":"2014","author":"T Lazer","year":"2014","unstructured":"Lazer T, Dar S, Shlush E, et al. Comparison of IVF outcomes between minimal stimulation and high-dose stimulation for patients with poor ovarian reserve. Int J Reprod Med. 2014;2014: 581451. https:\/\/doi.org\/10.1155\/2014\/581451.","journal-title":"Int J Reprod Med"},{"issue":"1","key":"2393_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13048-020-00666-z","volume":"13","author":"M Shapira","year":"2020","unstructured":"Shapira M, Orvieto R, Lebovitz O, et al. Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders? J Ovarian Res. 2020;13(1):66. https:\/\/doi.org\/10.1186\/s13048-020-00666-z.","journal-title":"J Ovarian Res"},{"issue":"9","key":"2393_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.18502\/ijrm.v17i9.5101","volume":"17","author":"A Moini","year":"2019","unstructured":"Moini A, Lavasani Z, Kashani L, Mojtahedi MF, Yamini N. Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial. Int J Reprod Biomed. 2019;17(9):653\u201360. https:\/\/doi.org\/10.18502\/ijrm.v17i9.5101.","journal-title":"Int J Reprod Biomed"},{"issue":"4","key":"2393_CR28","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00404-022-06676-0","volume":"306","author":"A Kahraman","year":"2022","unstructured":"Kahraman A, Tulek F. Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders. Arch Gynecol Obstet. 2022;306(4):1313\u20139. https:\/\/doi.org\/10.1007\/s00404-022-06676-0.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2393_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/humrep\/der452","volume":"27","author":"PB Miller","year":"2012","unstructured":"Miller PB, Parnell BA, Bushnell G, et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod. 2012;27(3):881\u20138. https:\/\/doi.org\/10.1093\/humrep\/der452.","journal-title":"Hum Reprod"},{"key":"2393_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.780392","volume":"12","author":"HT Lin","year":"2022","unstructured":"Lin HT, Wu MH, Tsai LC, Chen TS, Ou HT. Co-administration of clomiphene citrate and letrozole in mild ovarian stimulation versus conventional controlled ovarian stimulation among POSEIDON group 4 patients. Front Endocrinol (Lausanne). 2022;12: 780392. https:\/\/doi.org\/10.3389\/fendo.2021.780392.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2393_CR31","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.2147\/DDDT.S338748","volume":"15","author":"Y Lin","year":"2021","unstructured":"Lin Y, Chen Q, Zhu J, Teng Y, Huang X, Chen X. Progestin-primed ovarian stimulation with clomiphene citrate supplementation may be more feasible for young women with diminished ovarian reserve compared with standard progestin-primed ovarian stimulation: a retrospective study. Drug Des Devel Ther. 2021;15:5087\u201397. https:\/\/doi.org\/10.2147\/DDDT.S338748.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"2393_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","volume":"15","author":"LG Westergaard","year":"2000","unstructured":"Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15(5):1003\u20138. https:\/\/doi.org\/10.1093\/humrep\/15.5.1003.","journal-title":"Hum Reprod"},{"issue":"3","key":"2393_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0015-0282(00)01745-3","volume":"75","author":"MA Esposito","year":"2001","unstructured":"Esposito MA, Barnhart KT, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle- stimulating hormone. Fertil Steril. 2001;75(3):519\u201324. https:\/\/doi.org\/10.1016\/S0015-0282(00)01745-3.","journal-title":"Fertil Steril"},{"key":"2393_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.801026","volume":"12","author":"X Tu","year":"2021","unstructured":"Tu X, You B, Jing M, Lin C, Zhang R. Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first in vitro fertilization cycle: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12: 801026. https:\/\/doi.org\/10.3389\/fendo.2021.801026.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2393_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.rbmo.2016.02.013","volume":"32","author":"Y Yang","year":"2016","unstructured":"Yang Y, Sun X, Cui L, et al. Younger poor ovarian response women achieved better pregnancy results in the first three IVF cycles. Reprod Biomed Online. 2016;32(5):532\u20137. https:\/\/doi.org\/10.1016\/j.rbmo.2016.02.013.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"2393_CR36","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/humrep\/dew183","volume":"31","author":"MG Minasi","year":"2016","unstructured":"Minasi MG, Colasante A, Riccio T, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016;31(10):2245\u201354. https:\/\/doi.org\/10.1093\/humrep\/dew183.","journal-title":"Hum Reprod"},{"issue":"1","key":"2393_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12905-022-02126-w","volume":"22","author":"A Liu","year":"2022","unstructured":"Liu A, Li J, Shen H, Zhang L, Li Q, Zhang X. Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study. BMC Women\u2019s Health. 2022;22(1):527. https:\/\/doi.org\/10.1186\/s12905-022-02126-w.","journal-title":"BMC Women\u2019s Health"},{"key":"2393_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejogrb.2020.05.026","volume":"251","author":"O Triantafyllidou","year":"2020","unstructured":"Triantafyllidou O, Sigalos G, Gkoles L, et al. The addition of clomiphene citrate to ovarian stimulation protocols for poor responders. Eur J Obstet Gynecol Reprod Biol. 2020;251:136\u201340. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.026.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"2393_CR39","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10815-020-01755-0","volume":"37","author":"I Zolfaroli","year":"2020","unstructured":"Zolfaroli I, Ferriol GA, Mora JJH, Cano A. Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis. J Assist Reprod Genet. 2020;37(5):1203\u201312. https:\/\/doi.org\/10.1007\/s10815-020-01755-0.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"2393_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/humupd\/dmaa055","volume":"27","author":"J Pundir","year":"2021","unstructured":"Pundir J, Achilli C, Bhide P, et al. Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(3):474\u201385. https:\/\/doi.org\/10.1093\/humupd\/dmaa055.","journal-title":"Hum Reprod Update"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02393-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T21:28:56Z","timestamp":1745270936000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02393-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conformed to the Declaration of Helsinki for medical research involving Human Subjects and approval was obtained from the Ethical Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (approval number: TJ-IRB20210528).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}